6S8-13334-99398
4 vaccinations
5 coded responses
33 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 480 / MI
- Registered
- 2022-07-08
- Relationship
- Child or adolescent in my care
- Guardian
- BWS-50945-50983
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Dose 1 — Pfizer-BioNTech
-
2022-07-08
Registered in v-safe
- 2022-07-08
-
2022-07-10
Survey response — day 14, dose 1, under 3MedDRA: Excessive eye blinking, Fatigue — Feeling: FairFree text: The last few days he has been blinking his eyes frequently, complaining of fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-16
Dose 2 — Pfizer-BioNTech
-
2022-07-16
Survey response — day 0, dose 2, under 3MedDRA: Psychomotor hyperactivity — Feeling: GoodFree text: He's hyper this evening.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-17
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Psychomotor hyperactivity — Feeling: GoodFree text: He is hyper again, today.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-18
- 2022-07-19
-
2022-07-21
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-07-22
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Attention-seeking behaviour, Dependent personality disorder, Depressed mood — Feeling: GoodFree text: Clinginess, need for extra hugs, woeful.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-23
- 2022-07-30
- 2022-08-06
- 2022-08-13
- 2022-08-20
- 2022-08-27
-
2022-09-11
Dose 3 — Pfizer-BioNTech
- 2022-09-17
- 2022-09-18
- 2022-09-25
- 2022-10-09
- 2022-10-16
- 2022-10-23
- 2022-12-11
- 2023-03-12
-
2023-04-21
Dose 4 — Pfizer-BioNTech
-
2023-04-23
Health check-in — days 1–6 daily, dose 4, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2023-04-24
-
2023-04-25
Health check-in — days 1–6 daily, dose 4, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2023-04-26
- 2023-04-27
-
2023-04-28
Survey response — day 7, dose 4, under 3MedDRA: Insomnia — Feeling: Poor · Irritability/cryingMedDRA releases: 2024-11
- 2023-05-05
- 2023-05-12
- 2023-05-19
- 2023-05-26
- 2023-06-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
| 2 | 2022-07-16 | Pfizer-BioNTech | No |
| 3 | 2022-09-11 | Pfizer-BioNTech | No |
| 4 | 2023-04-21 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: The last few days he has been blinking his eyes frequently, complaining of fatigue.
Release 12 (Under 3) — day 0, dose 2, under 3
Systemic reaction (other): He's hyper this evening.
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): He is hyper again, today.
Systemic reaction (other): Clinginess, need for extra hugs, woeful.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Excessive eye blinking | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SRO | Attention-seeking behaviour | · | · | ✓ |
| SRO | Dependent personality disorder | · | · | ✓ |
| SRO | Depressed mood | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Psychomotor hyperactivity | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release